Symposium 13: Reach and meaning of the sarcopenia in T2D
DOI:
https://doi.org/10.47196/diab.v54i3Sup.323Keywords:
sarcopenia, diabetesAbstract
Symposium 13: Sarcopenia and diabetes
Reach and meaning of the sarcopenia in T2D
Clinically defined, we understand sarcopenia as the progressive and generalized loss of mass and skeletal muscle strength, which leads to a decrease in physical performance. Three stages of evolution tend to be distinguished as: 1- Presarcopenia. Muscle mass reduced without an impact on strength or performance; 2- Sarcopenia. Muscle mass reduced with a reduction of strength or performance; 3- Severe sarcopenia. The three criteria are present. Sarcopenia is more frequent in patients with obesity and also in patients with diabetes.
It has been estimated that the presence of diabetes increases the risk of sarcopenia a 50% when it is adapted to age, sex and other variables. Sarcopenia seems to be associated with a mortality excess and it increases the risk of fallings or fractures, especially in patients with diabetes (in interaction with the increase of bone fragility and other factors such as neuropathy, visual alterations, obesity, arrhythmia, and hypoglycemia).
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
